- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04633109
The Obese Taste Bud Study (OTB)
January 13, 2021 updated by: Imke Schamarek, University of Leipzig
The sense of taste is essential for priming food preferences and is therefore important for caloric uptake and body weight regulation.
Recent studies show that obesity is linked to changes in taste sensation but also to a loss of taste buds on the tongue.
This study aims to evaluate underlying mechanisms within the taste buds to potentially influence the sense of taste on the level of these sensory cells and in order to develop new treatment strategies to fight obesity.
Study Overview
Status
Recruiting
Conditions
Study Type
Observational
Enrollment (Anticipated)
210
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Imke Schamarek, Dr.
- Phone Number: +493419713803
- Email: Imke.Schamarek@medizin.uni-leipzig.de
Study Contact Backup
- Name: Kerstin Rohde-Zimmermann, Dr.
- Phone Number: +493419722932
- Email: Kerstin.Rohde@helmholtz-muenchen.de
Study Locations
-
-
Saxony
-
Leipzig, Saxony, Germany, 04103
- Recruiting
- Medical Clinic III, Division of Endocrinology, University Clinic of Leipzig
-
Contact:
- Imke Schamarek, Dr. med.
- Phone Number: +493419713803
- Email: imke.schamarek@medizin.uni-leipzig.de
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 69 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
the study population will mainly consits of patients who underwent a medically induced elective surgery at the head or neck area (f.e.
surgery at the soft palate, plastic surgery, maintenance of congenital anomalies etc.) or healthy participants recruited elsewhere at the campus area of the Medical Faculty of the University of Leipzig, Saxony, Germany.
Description
Inclusion Criteria:
- normal weight (BMI 18.5-24.9)
- obesity (BMI >=30)
- overall healthy (no severe sickness, no cancer)
- written informed consent
Exclusion Criteria:
- current pregnancy or currently breastfeeding
- cancer or tumors
- state after radiotherapy at head-neck area
- state after or current chemotherapy
- severe psychiatric-, cardiac-, kidney- or neurological illness
- diagnosed diabetes mellitus
- known dysfunction of smelling or tasting
- drug or alcohol abuse
- permanent medication with antidepressants, anticonvulsants, steroids and/or immunosuppressants
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Case-Control
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
normal weight
Normal weight adults with BMI ranging from 18.5-24.9;
men and women; age range 18-69years; written informed consent
|
Taste buds will be surgically removed a) during a planned and medically induced elective surgery under full anesthesia; b) by local anesthesia in subjects without a medically induced surgery
75g glucose will be applied in drinking water following blood sample collection to evaluate glucose, insulin and C-peptide level.
Subjects are given taste strips with 4 concentrations per each taste quality of sweet, sour, salty, bitter and umami in a pseudo-randomized manner.
Subjects are asked to identify the taste quality, state the intensity, preference and certainty.
Subjects will be presented 16 different sniffing sticks in a randomized order, each for about 4seconds.
People are then asked to identify the smell by choosing one out of 4 options (forced choice).
The number of taste buds on the anterior tongue will be determined by colouring the tongue surface with food colour.
Taste buds will apply more reddish as compared to non-taste tissue.
Based on a digital photography the number of taste buds per subjects is counted manually.
Anthropometric data collection will include measures of body height, body weight, arm-, upper- and lower leg circumferences, waist- and hip circumferences and a bioimpedance analysis to obtain data about body composition.
Blood and saliva samples will be taken as well as a tongue swab.
Through the use of several questionnaires, data about eating behavior, food preferences, life style factors and other will be obtained.
|
|
obese
Subjects with obesity as defined by BMI >= 30; men and women; age range 18-69 years; written informed consent
|
Taste buds will be surgically removed a) during a planned and medically induced elective surgery under full anesthesia; b) by local anesthesia in subjects without a medically induced surgery
75g glucose will be applied in drinking water following blood sample collection to evaluate glucose, insulin and C-peptide level.
Subjects are given taste strips with 4 concentrations per each taste quality of sweet, sour, salty, bitter and umami in a pseudo-randomized manner.
Subjects are asked to identify the taste quality, state the intensity, preference and certainty.
Subjects will be presented 16 different sniffing sticks in a randomized order, each for about 4seconds.
People are then asked to identify the smell by choosing one out of 4 options (forced choice).
The number of taste buds on the anterior tongue will be determined by colouring the tongue surface with food colour.
Taste buds will apply more reddish as compared to non-taste tissue.
Based on a digital photography the number of taste buds per subjects is counted manually.
Anthropometric data collection will include measures of body height, body weight, arm-, upper- and lower leg circumferences, waist- and hip circumferences and a bioimpedance analysis to obtain data about body composition.
Blood and saliva samples will be taken as well as a tongue swab.
Through the use of several questionnaires, data about eating behavior, food preferences, life style factors and other will be obtained.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Identification of differential gene and protein regulation in isolated human taste cells between lean and obese subjects
Time Frame: through study completion, an average of 2 years
|
Transcriptomics (RNAsequencing (seq), single cell seq) and epigenomics (open chromatin mapping (ATACseq), Infinium MethylationEPIC Array) will be performed in isolated papillae fungiformes.
Validation analyses by in vitro primary cell cultures of taste cell biopsy
|
through study completion, an average of 2 years
|
|
Identification of correlations between taste cell biology with parameters of intervention
Time Frame: 1 year
|
corrleation analyses will include factors of eating behavior, food preferences, life style factors, data from taste and smell screenings, anthropometric data, blood and saliva parameters
|
1 year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Differences of salivary and tongue microbiome on taste cells in obesity in contrast to lean
Time Frame: 2 years
|
whole mouth saliva as well as local tongue microbiome diversity will be analysed by 16S ribosomal RNA seq and related to further parameters of this study.
|
2 years
|
|
extracellular vesicle analyses of saliva in lean and obese subjects
Time Frame: 2 years
|
The content of extracellular vesicles from saliva samples will be analysed and compared between the study groups as well as related to other parameters of this study.
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Study Director: Michael Stumvoll, Prof. Dr., Medical Faculty of the University of Leipzig, Leipzig, Germany
- Principal Investigator: Imke Schamarek, Dr., Medical Faculty of the University of Leipzig, Leipzig, Germany
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 9, 2020
Primary Completion (Anticipated)
July 15, 2022
Study Completion (Anticipated)
July 30, 2022
Study Registration Dates
First Submitted
November 6, 2020
First Submitted That Met QC Criteria
November 16, 2020
First Posted (Actual)
November 18, 2020
Study Record Updates
Last Update Posted (Actual)
January 14, 2021
Last Update Submitted That Met QC Criteria
January 13, 2021
Last Verified
January 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- OTB-2020
- DRKS00022950 (Registry Identifier: DRKS)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
IPD Plan Description
one aim of this study is to obtain large-scale sequencing data.
with this several not yet defined research questions will be generated which shall be explored through later analyses and projects.
in order to exploit the potential of the data and to avoid misinterpretation, the data should only be accessible to the scientists and collaborators involved.
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on taste bud biopsy
-
Bournemouth UniversityEnrolling by invitationDietary Behavior | Free Sugar | Sweet TasteUnited Kingdom
-
Penn State UniversityCompletedBehavior, HealthUnited States
-
Wake Forest University Health SciencesRecruiting
-
Yağmur MalkocIstanbul Medipol University HospitalCompleted
-
Centre Hospitalier Universitaire DijonRecruitingUnder-consumption of FoodFrance
-
Egas Moniz - Cooperativa de Ensino Superior, CRLCompleted
-
University Medical Center GroningenRecruitingMetastatic Triple Negative Breast Cancer or Metastatic Testicular Cancer, or Stage II-IV Diffuse Large B Cell LymphomaNetherlands
-
Purdue UniversityCompleted
-
University of Missouri-ColumbiaCompleted
-
Wageningen UniversityUnknown